Glenmede Trust’s Integra LifeSciences IART Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $17M | Sell |
948,142
-36,544
| -4% | -$511K | 0.08% | 227 |
|
|
2026
Q1 | $9.28M | Buy |
984,686
+211,774
| +27% | +$2.33M | 0.05% | 349 |
|
|
2025
Q4 | $9.6M | Buy |
+772,912
| New | +$10.3M | 0.05% | 348 |
|
|
2025
Q1 | $15.5M | Sell |
704,325
-17,486
| -2% | -$411K | 0.08% | 234 |
|
|
2024
Q4 | $16.4M | Sell |
721,811
-5,970
| -0.8% | -$130K | 0.08% | 247 |
|
|
2024
Q3 | $13.2M | Buy |
727,781
+405,624
| +126% | +$9.4M | 0.06% | 313 |
|
|
2024
Q2 | $9.39M | Buy |
322,157
+2,737
| +0.9% | +$81.2K | 0.05% | 358 |
|
|
2024
Q1 | $11.3M | Buy |
319,420
+22,842
| +8% | +$914K | 0.06% | 349 |
|
|
2023
Q4 | $12.9M | Sell |
296,578
-9,454
| -3% | -$372K | 0.07% | 304 |
|
|
2023
Q3 | $11.7M | Buy |
306,032
+95,857
| +46% | +$4.03M | 0.07% | 303 |
|
|
2023
Q2 | $11.9M | Buy |
210,175
+408
| +0.2% | +$19.6K | 0.07% | 307 |
|
|
2023
Q1 | $12M | Buy |
+209,767
| New | +$11.8M | 0.07% | 299 |
|
|
2022
Q2 | – | Sell |
-3,292
| Closed | -$211K | – | 1329 |
|
|
2022
Q1 | $211K | Sell |
3,292
-151
| -4% | -$9.94K | ﹤0.01% | 1121 |
|
|
2021
Q4 | $230K | Sell |
3,443
-260
| -7% | -$17.6K | ﹤0.01% | 1113 |
|
|
2021
Q3 | $253K | Sell |
3,703
-312
| -8% | -$22K | ﹤0.01% | 1074 |
|
|
2021
Q2 | $273K | Buy |
4,015
+126
| +3% | +$8.91K | ﹤0.01% | 1056 |
|
|
2021
Q1 | $268K | Sell |
3,889
-1,766
| -31% | -$120K | ﹤0.01% | 1000 |
|
|
2020
Q4 | $367K | Sell |
5,655
-824
| -13% | -$44.3K | ﹤0.01% | 920 |
|
|
2020
Q3 | $305K | Buy |
6,479
+323
| +5% | +$15.4K | ﹤0.01% | 915 |
|
|
2020
Q2 | $289K | Buy |
6,156
+1,640
| +36% | +$80.6K | ﹤0.01% | 917 |
|
|
2020
Q1 | $263K | Hold |
4,516
| – | – | ﹤0.01% | 1094 |
|
|
2019
Q4 | $263K | Buy |
4,516
+21
| +0.5% | +$1.25K | ﹤0.01% | 1094 |
|
|
2019
Q3 | $270K | Buy |
4,495
+89
| +2% | +$5.3K | ﹤0.01% | 1057 |
|
|
2019
Q2 | $246K | Hold |
4,406
| – | – | ﹤0.01% | 1093 |
|
|
2019
Q1 | $245K | Sell |
4,406
-3
| -0.1% | -$153 | ﹤0.01% | 1107 |
|
|
2018
Q4 | $198K | Sell |
4,409
-344,546
| -99% | -$18.9M | ﹤0.01% | 1120 |
|
|
2018
Q3 | $23M | Sell |
348,955
-422,924
| -55% | -$26.3M | 0.09% | 300 |
|
|
2018
Q2 | $49.7M | Sell |
771,879
-318,954
| -29% | -$19.8M | 0.22% | 136 |
|
|
2018
Q1 | $52.2M | Hold |
1,090,833
| – | – | 0.22% | 127 |
|
|
2017
Q4 | $52.2M | Sell |
1,090,833
-11,836
| -1% | -$579K | 0.22% | 127 |
|
|
2017
Q3 | $55.7M | Sell |
1,102,669
-21,260
| -2% | -$1.09M | 0.24% | 116 |
|
|
2017
Q2 | $47.3M | Hold |
1,123,929
| – | – | 0.23% | 125 |
|
|
2017
Q1 | $47.3M | Buy |
1,123,929
+1,120,597
| +33,631% | +$47.9M | 0.23% | 125 |
|
|
2016
Q4 | $142K | Buy |
3,332
+362
| +12% | +$14.7K | ﹤0.01% | 1297 |
|
|
2016
Q3 | $122K | Buy |
+2,970
| New | +$124K | ﹤0.01% | 1344 |
|
Other funds holding IART
RCMNY
PCMI
Glenmede Trust's IART Position: Q2 2026 in Review
Glenmede Trust reduced its Integra LifeSciences (IART) stake by 3.7% in Q2 2026, selling an estimated $511K and leaving 948,142 shares worth $17M. The position accounts for 0.08% of the portfolio, ranked #227.
Glenmede Trust first reported a position in IART in Q3 2016 and has held it in 35 quarters since. The position peaked at $55.7M in Q3 2017. 212 funds tracked by Wall St. Rank hold IART as of Q2 2026.
- Glenmede Trust held 948,142 shares of Integra LifeSciences worth $17M as of Q2 2026.
- Glenmede Trust sold 36,544 Integra LifeSciences shares in Q2 2026, an estimated $511K.
- Integra LifeSciences made up 0.08% of Glenmede Trust's portfolio in Q2 2026, its #227 holding.
- Glenmede Trust first reported a position in Integra LifeSciences in Q3 2016 and has held it in 35 quarters since.
- Glenmede Trust's Integra LifeSciences position peaked at $55.7M in Q3 2017.
- 212 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.
Based on Glenmede Trust's 13F filing for Q2 2026, filed 10 Aug 2026.